Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Flores MK, Janes JL, Islam M, Wan J, Liu J, Reams RR, Su LM, Yen K, Mehta HH, Reagan A, Howard LE, Wiggins E, Vidal AC, Freedland SJ, Cohen P. Mitochondrial DNA Copy-Number Assessment Is a Potent Predictor for Prostate Cancer in White but Not Black Individuals. Cancer Prev Res (Phila). 2025 Sep 02; 18(9):541-550.
-
Bertini A, Tylecki A, Stephens A, Finocchiaro A, Vigan? S, Cusmano N, Dinesh A, Guivatchian E, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Rogers C, Abdollah F. Socioeconomic Disparities in Prostate Cancer Presentation: The Impact of ADI on Prostate Cancer Stage at Diagnosis. Clin Genitourin Cancer. 2025 Dec; 23(6):102418.
-
Bertini A, Stephens A, Finocchiaro A, Vigan? S, Perri A, Lughezzani G, Buffi N, Sorce G, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Menon M, Rogers C, Abdollah F. Mortality and Additional Treatment Rates in Pathologically High-Risk Prostate Cancer With Prostate-Specific Antigen Persistence at Robot-Assisted Radical Prostatectomy: Long-Term Report From Single Tertiary Referral Center. Prostate. 2025 Dec; 85(16):1457-1467.
-
Bertini A, Stephens A, Finocchiaro A, Vigan? S, Dinesh A, Guivatchian E, Perri A, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Menon M, Rogers C, Abdollah F. Long-term Cancer Control Outcomes After Robot-assisted Radical Prostatectomy in Pathologically Non-organ-confined High-risk Prostate Cancer: 20-year Report from a Single Tertiary Referral Center. Eur Urol Focus. 2025 Nov; 11(6):904-911.
-
Baker MJ, Zhang S, Zhang D, Searle J, Lal P, Vlaar CP, Dharmawardhane S, Abba MC, Kazanietz MG, Cooke M. VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer. Mol Cancer Res. 2025 Aug 04; 23(8):684-698.
-
Bertini A, Cirulli GO, Stephens A, Finocchiaro A, Vigan? S, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Salonia A, Briganti A, Montorsi F, Sood A, Rogers C, Abdollah F. Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency. BJU Int. 2025 Nov; 136(5):818-825.
-
Okpattah D, Karki A, Pillarsetty NVK, Harding WW. Synthesis and evaluation of aporphinoid 5-HT7AR ligands as inhibitors of PC3 prostate cancer cell growth. Bioorg Med Chem Lett. 2025 Dec 01; 128:130328.
-
Bertini A, Stephens A, Finocchiaro A, Silvia V, Arjun D, Elnaz G, Nicholas C, Lughezzani G, Buffi N, Di Trapani E, Ficarra V, Briganti A, Salonia A, Montorsi F, Sood A, Rogers C, Abdollah F. Association of Area of Deprivation Index With Active Surveillance (AS) Utilization and Adherence to as Guidelines: Results From a Contemporary North American Cohort. Prostate. 2025 Aug; 85(11):1024-1035.
-
Johnson R, Caggia S, Khan SA. Gai2 Induces Cell Migration in PC3 Prostate Cancer Cells in the Absence of Rac1 Activation. Int J Mol Sci. 2025 Mar 15; 26(6).
-
Vigan? S, Finati M, Stephens A, Bertini A, Finocchiaro A, Lughezzani G, Buffi N, Salonia A, Briganti A, Montorsi F, Rossanese M, Di Trapani E, Ficarra V, Sood A, Rogers C, Abdollah F. Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American Cohort. Prostate. 2025 Jun; 85(8):758-766.